Related changes

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options

Legend:

N: This edit created a new page (also see list of new pages)
m: This is a minor edit
b: This edit was performed by a bot
(±123): The page size changed by this number of bytes

Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 14:49, 25 February 2021

23 February 2021

		m 15:37	Rituximab (Rituxan)‎‎ (3 changes \| history) . . (+378)‎ . . [Jwarner‎ (3×)]
		m	15:37 (cur \| prev) . . (-145)‎ . . Jwarner (talk \| contribs) (→‎History of changes in FDA indication)
		m	15:36 (cur \| prev) . . (-1)‎ . . Jwarner (talk \| contribs) (→‎Indolent (Low grade) lymphoma)
		m	15:36 (cur \| prev) . . (+524)‎ . . Jwarner (talk \| contribs) (→‎History of changes in FDA indication)

Namespace:	Invert selection Associated namespace
Tag filter:
Page name:	Show changes to pages linked to the given page instead

		m 15:37	Rituximab (Rituxan)‎‎ (3 changes \| history) . . (+378)‎ . . [Jwarner‎ (3×)]
		m	15:37 (cur \| prev) . . (-145)‎ . . Jwarner (talk \| contribs) (→‎History of changes in FDA indication)
		m	15:36 (cur \| prev) . . (-1)‎ . . Jwarner (talk \| contribs) (→‎Indolent (Low grade) lymphoma)
		m	15:36 (cur \| prev) . . (+524)‎ . . Jwarner (talk \| contribs) (→‎History of changes in FDA indication)

Related changes

23 February 2021

Navigation menu

Personal tools

Namespaces

Variants

Views

More

Search

Index

Top pages

References

Stay in touch

Contributors

Tools